SE8200403L - Hybridceller, antikroppar, sett for framstellning av hybridceller, som producerar en antikropp samt sett for framstellning av antikroppar - Google Patents

Hybridceller, antikroppar, sett for framstellning av hybridceller, som producerar en antikropp samt sett for framstellning av antikroppar

Info

Publication number
SE8200403L
SE8200403L SE8200403A SE8200403A SE8200403L SE 8200403 L SE8200403 L SE 8200403L SE 8200403 A SE8200403 A SE 8200403A SE 8200403 A SE8200403 A SE 8200403A SE 8200403 L SE8200403 L SE 8200403L
Authority
SE
Sweden
Prior art keywords
producing
hybrids
antibodies
hybrid cells
kit
Prior art date
Application number
SE8200403A
Other languages
Unknown language ( )
English (en)
Swedish (sv)
Inventor
H-K Hochkeppel
Ley M De
Original Assignee
Biotechnolog Forschung Gmbh
Rega Instituut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19823200657 external-priority patent/DE3200657A1/de
Application filed by Biotechnolog Forschung Gmbh, Rega Instituut filed Critical Biotechnolog Forschung Gmbh
Publication of SE8200403L publication Critical patent/SE8200403L/

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/249—Interferons

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SE8200403A 1981-01-28 1982-01-26 Hybridceller, antikroppar, sett for framstellning av hybridceller, som producerar en antikropp samt sett for framstellning av antikroppar SE8200403L (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE3102772 1981-01-28
DE3122832 1981-06-09
DE3143379 1981-11-02
DE19823200657 DE3200657A1 (de) 1981-01-28 1982-01-12 Verfahren zur herstellung von einen antikoerper produzierenden hybridzellen und von antikoerpern, hybridzellen und antikoerper

Publications (1)

Publication Number Publication Date
SE8200403L true SE8200403L (sv) 1982-07-29

Family

ID=27432623

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8200403A SE8200403L (sv) 1981-01-28 1982-01-26 Hybridceller, antikroppar, sett for framstellning av hybridceller, som producerar en antikropp samt sett for framstellning av antikroppar

Country Status (5)

Country Link
DK (1) DK37382A (da)
FI (1) FI820200L (da)
FR (1) FR2498626A1 (da)
GB (1) GB2092614A (da)
SE (1) SE8200403L (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0096839B1 (en) * 1982-06-09 1989-01-25 Asahi Kasei Kogyo Kabushiki Kaisha Method for producing human antibody
JPS59172496A (ja) * 1983-03-18 1984-09-29 Kyowa Hakko Kogyo Co Ltd モノクロ−ナル抗体
US4599306A (en) * 1983-04-15 1986-07-08 Amgen Monoclonal antibodies which specifically bind to human immune interferon
CA1340698C (en) * 1986-07-25 1999-08-10 Kabushiki Kaisha Hayashibara Seibutsu Kaguku Kenkyujo Preparation and uses of interferon-gamma

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3884758A (en) * 1974-01-30 1975-05-20 Massachusetts Inst Technology Triglyceride-accumulating clonal cell line
GB1540579A (en) * 1975-08-01 1979-02-14 Searle & Co Cell culture medium
FR2492842A1 (fr) * 1980-10-24 1982-04-30 Centre Nat Rech Scient Hybride cellulaire produisant un anticorps specifique de l'interferon leucocytaire humain et procede de formation d'hybrides cellulaires producteurs d'anticorps specifiques de l'interferon humain

Also Published As

Publication number Publication date
FI820200A7 (fi) 1982-07-29
FR2498626A1 (fr) 1982-07-30
GB2092614A (en) 1982-08-18
FI820200L (fi) 1982-07-29
DK37382A (da) 1982-07-29

Similar Documents

Publication Publication Date Title
Milstein Monoclonal antibodies
Stähli et al. High frequencies of antigen-specific hybridomas: dependence on immunization parameters and prediction by spleen cell analysis
ATE13198T1 (de) Hybridzellinie zur herstellung monoklonaler antikoerper gegen ein menschliches t-zellenantigen, antikoerper und verfahren.
ATE4778T1 (de) Verfahren zur herstellung von hepatitisvirusantik\rpern und zellstaemme hierfuer.
DK154087C (da) Monoklonalt antistof, fremstilling heraf, hybrodimacellelinie til anvendelse ved fremstilling heraf, fremgangsmaade til anvendelse heraf samt diagnostisk praeparat indeholdende antistoffet
ATE14899T1 (de) Hybridzellinie zur herstellung monoklonaler antikoerper gegen ein menschliches monozytantigen, antikoerper und verfahren.
JPS5695123A (en) Hybrid cell line* antibody and method for manufacturing monoclonal antibody to human prothymocyte cell
ATE14233T1 (de) Monoklonaler antikoerper gegen menschliche tzellen, verfahren zu seiner herstellung, ihn produzierende hybridzellinie, ihn enthaltende therapeutische zusammensetzung und ihn verwendendes diagnostisches verfahren.
AU7729594A (en) Methods and composition for the modulation of host immune response to allergens
ATE13692T1 (de) Hybridzellinie zur herstellung komplementfixierender monoklonaler antikoerper gegen menschliche suppressor-t-zellen; antikoerper und verfahren zu seiner herstellung; diagnostische und therapeutische verwendungen und diesen antikoerper enthaltende pharmazeutische zusammensetzungen.
ES8200559A1 (es) Un anticuerpo monoclonal
AU6496180A (en) Hybridoma for producing monoclonal antibodies
YU306680A (en) Method of obtaining monoclonal antibodies
DE3582358D1 (de) Monoklonaler antikoerper und verfahren zur quantitativen bestimmung von immunoglobulinen mittels dieses antikoerpers.
DE3581288D1 (de) Antileishmania monoklonale antikoerper, diese antikoerper ausscheidende hybridomas, von diesen antikoerpern erkannte leishmaniaantigene, verfahren zur herstellung und verwendung von diesen monoklonalen antikoerpern und antigenen.
ATE217888T1 (de) Monoklonale antikörper gegen leukozyten- spezifische g-protein-gekoppelte rezeptoren
DE3576359D1 (de) Verfahren zur herstellung von tumorspezifische monoklonale antikoerper produzierenden hybridomazellen.
EP0131878A3 (en) Process for producing human monoclonal antibodies
EP0225583A3 (en) Monoclonal anti-human granulocyte colony stimulating factor antibody
DE3783002D1 (de) Neue monoklonale antikoerper gegen ifn-omega, verfahren zu ihrer herstellung und deren verwendung zur reinigung sowie zum nachweis von ifn-omega.
EP0155172A3 (en) Anti-human lung cancer monoclonal antibodies
EP0300740A3 (en) Monoclonal antibodies to complement c5a
ES8401982A1 (es) "procedimiento de preparacion de globulina antilinfocitaria t".
EP0119859A3 (en) Monoclonal antibodies, processes for their preparation and methods for their use
ATE79134T1 (de) Verfahren zur auslese von hybridomen, die spezifische antikoerper gegen unzugaengliche zelloberflaecheantigene erzeugen.

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8200403-7

Format of ref document f/p: F